Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
11284 | 993 | 32.7 | 67% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
111 | 3 | THROMBOSIS RESEARCH//THROMBOSIS AND HAEMOSTASIS//HEMATOLOGY | 71244 |
1214 | 2 | FACTOR XIII//TRANSGLUTAMINASE//TRANSGLUTAMINASE 2 | 9158 |
11284 | 1 | FACTOR XIII//FACTOR XIII DEFICIENCY//MOL PATHOBIOCHEM PATHOBIOL | 993 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | FACTOR XIII | authKW | 3498504 | 21% | 54% | 212 |
2 | FACTOR XIII DEFICIENCY | authKW | 1897637 | 7% | 86% | 72 |
3 | MOL PATHOBIOCHEM PATHOBIOL | address | 520912 | 2% | 71% | 24 |
4 | FXIII DEFICIENCY | authKW | 399738 | 1% | 100% | 13 |
5 | FACTOR XIIIA | authKW | 304152 | 4% | 27% | 36 |
6 | COAGULATION FACTOR XIII | authKW | 291534 | 2% | 59% | 16 |
7 | FXIII | authKW | 256229 | 2% | 56% | 15 |
8 | FACTOR XIII VAL34LEU POLYMORPHISM | authKW | 218658 | 1% | 89% | 8 |
9 | FXIII A | authKW | 215244 | 1% | 100% | 7 |
10 | ALI EBN E ABITALEB HOSP | address | 191585 | 1% | 69% | 9 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Hematology | 20105 | 43% | 0% | 430 |
2 | Peripheral Vascular Diseases | 5798 | 23% | 0% | 226 |
3 | Dermatology | 476 | 6% | 0% | 57 |
4 | Medical Laboratory Technology | 221 | 3% | 0% | 27 |
5 | Pathology | 205 | 5% | 0% | 47 |
6 | Biochemistry & Molecular Biology | 166 | 15% | 0% | 150 |
7 | Genetics & Heredity | 91 | 5% | 0% | 54 |
8 | Medicine, Research & Experimental | 52 | 4% | 0% | 39 |
9 | Biochemical Research Methods | 41 | 3% | 0% | 31 |
10 | Biophysics | 23 | 3% | 0% | 29 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MOL PATHOBIOCHEM PATHOBIOL | 520912 | 2% | 71% | 24 |
2 | ALI EBN E ABITALEB HOSP | 191585 | 1% | 69% | 9 |
3 | THROMBOSIS HEMOSTASIS VASC BIOL GRP | 167409 | 1% | 78% | 7 |
4 | RCCAH | 128120 | 1% | 83% | 5 |
5 | MOL PATHOBIOCHEM BIOL | 122996 | 0% | 100% | 4 |
6 | THROMBOSIS HAEMOSTASIS VASC BIOL GRP | 98387 | 1% | 40% | 8 |
7 | THROMBOSIS KINDERKLIN G3 | 92247 | 0% | 100% | 3 |
8 | UNIT MOL VASC MED | 82806 | 2% | 14% | 19 |
9 | ALI EBN E ABITALEB HOSP CHILDREN ADOLES | 61498 | 0% | 100% | 2 |
10 | CLIN THROMBOSISMED HLTH SCI | 61498 | 0% | 100% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | THROMBOSIS AND HAEMOSTASIS | 22792 | 9% | 1% | 86 |
2 | THROMBOSIS RESEARCH | 8709 | 5% | 1% | 54 |
3 | HAEMOPHILIA | 7243 | 3% | 1% | 27 |
4 | BLOOD COAGULATION & FIBRINOLYSIS | 6793 | 3% | 1% | 27 |
5 | JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 6575 | 3% | 1% | 29 |
6 | SEMINARS IN THROMBOSIS AND HEMOSTASIS | 3338 | 2% | 1% | 17 |
7 | BLOOD | 2840 | 6% | 0% | 57 |
8 | BRITISH JOURNAL OF HAEMATOLOGY | 1877 | 3% | 0% | 29 |
9 | HAMOSTASEOLOGIE | 1128 | 0% | 1% | 4 |
10 | ARZTLICHE LABORATORIUM | 1085 | 0% | 2% | 2 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | FACTOR XIII | 3498504 | 21% | 54% | 212 | Search FACTOR+XIII | Search FACTOR+XIII |
2 | FACTOR XIII DEFICIENCY | 1897637 | 7% | 86% | 72 | Search FACTOR+XIII+DEFICIENCY | Search FACTOR+XIII+DEFICIENCY |
3 | FXIII DEFICIENCY | 399738 | 1% | 100% | 13 | Search FXIII+DEFICIENCY | Search FXIII+DEFICIENCY |
4 | FACTOR XIIIA | 304152 | 4% | 27% | 36 | Search FACTOR+XIIIA | Search FACTOR+XIIIA |
5 | COAGULATION FACTOR XIII | 291534 | 2% | 59% | 16 | Search COAGULATION+FACTOR+XIII | Search COAGULATION+FACTOR+XIII |
6 | FXIII | 256229 | 2% | 56% | 15 | Search FXIII | Search FXIII |
7 | FACTOR XIII VAL34LEU POLYMORPHISM | 218658 | 1% | 89% | 8 | Search FACTOR+XIII+VAL34LEU+POLYMORPHISM | Search FACTOR+XIII+VAL34LEU+POLYMORPHISM |
8 | FXIII A | 215244 | 1% | 100% | 7 | Search FXIII+A | Search FXIII+A |
9 | FACTOR XIII POLYMORPHISM | 158136 | 1% | 86% | 6 | Search FACTOR+XIII+POLYMORPHISM | Search FACTOR+XIII+POLYMORPHISM |
10 | PLASMA TRANSGLUTAMINASE | 158136 | 1% | 86% | 6 | Search PLASMA+TRANSGLUTAMINASE | Search PLASMA+TRANSGLUTAMINASE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | MUSZBEK, L , BERECZKY, Z , BAGOLY, Z , KOMAROMI, I , KATONA, E , (2011) FACTOR XIII: A COAGULATION FACTOR WITH MULTIPLE PLASMATIC AND CELLULAR FUNCTIONS.PHYSIOLOGICAL REVIEWS. VOL. 91. ISSUE 3. P. 931-972 | 188 | 59% | 121 |
2 | DORGALALEH, A , RASHIDPANAH, J , (2016) BLOOD COAGULATION FACTOR XIII AND FACTOR XIII DEFICIENCY.BLOOD REVIEWS. VOL. 30. ISSUE 6. P. 461 -475 | 121 | 89% | 1 |
3 | MUSZBEK, L , YEE, VC , HEVESSY, Z , (1999) BLOOD COAGULATION FACTOR XIII: STRUCTURE AND FUNCTION.THROMBOSIS RESEARCH. VOL. 94. ISSUE 5. P. 271 -305 | 168 | 65% | 200 |
4 | SCHROEDER, V , KOHLER, HP , (2013) FACTOR XIII DEFICIENCY: AN UPDATE.SEMINARS IN THROMBOSIS AND HEMOSTASIS. VOL. 39. ISSUE 6. P. 632-641 | 81 | 94% | 22 |
5 | MUSZBEK, L , KATONA, E , (2016) DIAGNOSIS AND MANAGEMENT OF CONGENITAL AND ACQUIRED FXIII DEFICIENCIES.SEMINARS IN THROMBOSIS AND HEMOSTASIS. VOL. 42. ISSUE 4. P. 429 -439 | 61 | 94% | 3 |
6 | MUSZBEK, L , ADANY, R , MIKKOLA, H , (1996) NOVEL ASPECTS OF BLOOD COAGULATION FACTOR XIII .1. STRUCTURE, DISTRIBUTION, ACTIVATION, AND FUNCTION.CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES. VOL. 33. ISSUE 5. P. 357-421 | 148 | 65% | 133 |
7 | BISWAS, A , IVASKEVICIUS, V , SEITZ, R , THOMAS, A , OLDENBURG, J , (2011) AN UPDATE OF THE MUTATION PROFILE OF FACTOR 13 A AND B GENES.BLOOD REVIEWS. VOL. 25. ISSUE 5. P. 193 -204 | 63 | 91% | 22 |
8 | KARIMI, M , BERECZKY, Z , COHAN, N , MUSZBEK, L , (2009) FACTOR XIII DEFICIENCY.SEMINARS IN THROMBOSIS AND HEMOSTASIS. VOL. 35. ISSUE 4. P. 426 -438 | 54 | 96% | 90 |
9 | LEVY, JH , GREENBERG, C , (2013) BIOLOGY OF FACTOR XIII AND CLINICAL MANIFESTATIONS OF FACTOR XIII DEFICIENCY.TRANSFUSION. VOL. 53. ISSUE 5. P. 1120-1131 | 62 | 79% | 20 |
10 | MUSZBEK, L , BERECZKY, Z , BAGOLY, Z , SHEMIRANI, AH , KATONA, E , (2010) FACTOR XIII AND ATHEROTHROMBOTIC DISEASES.SEMINARS IN THROMBOSIS AND HEMOSTASIS. VOL. 36. ISSUE 1. P. 18 -33 | 77 | 73% | 16 |
Classes with closest relation at Level 1 |